CCNF p.Val640Met
c.1918G>A · rs373872375 · VCV1343314
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0991 | likely benign |
|---|---|---|
| REVEL | 0.112 | moderately benign-leaning |
| SaProt | LLR -7.90 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 5.1 | GERP 0.53, phastCons 1 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 8,082 bp · p 0.66 · regional, not allelic |
| Overall | ||
| CADD | 19.48 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00666% | 15,022 |
| Finnishnot grpmax-eligible | 0.00489% | 20,435 |
| European (non-Finnish)grpmax | 0.00234% | 42,775 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CCNF
- Protein
- p.Val640Met
- Coding
- c.1918G>A
- MANE Select
- NM_001761
- dbSNP
- rs373872375
- Type
- single nucleotide variant
- Location
- chr16:2456577 (GRCh38)
- Gene constraint
- LOEUF 0.531 · pLI 0.70 (gnomAD)
- Structure
- AlphaFold pLDDT 72.34 · 1 PDB
- Residue 640
- the 'pest' region
Disease context
amyotrophic lateral sclerosis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Amyotrophic lateral sclerosis (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, Not applicable
- Onset
- Adult
- Prevalence
- 1-9 / 100 000 (Europe)
Similar variants
- CCNF p.Arg140Gln Uncertain significance ★★ ⚠ same condition
- CCNF p.Glu575Asp Likely benign ★ same condition
- CCNF p.Leu209Val Likely benign ★ ⚠ same condition
- CCNF p.Ser621Gly Pathogenic/Likely pathogenic ★★ ⚠ same type
- CCNF p.Arg24Lys Uncertain significance ★★ ⚠ same type
- CCNF p.Arg572Gln Uncertain significance ★★ ⚠ same type
- CCNF p.Gly254Ala Uncertain significance ★★ ⚠ same type
- CCNF p.Gly719Val Uncertain significance ★★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ccnf-p-val640met (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown